342 related articles for article (PubMed ID: 36792928)
1. Reactive Oxygen Species and Ferroptosis at the Nexus of Inflammation and Colon Cancer.
Huang W; Aabed N; Shah YM
Antioxid Redox Signal; 2023 Sep; 39(7-9):551-568. PubMed ID: 36792928
[No Abstract] [Full Text] [Related]
2. Comparative analysis of single-cell transcriptome reveals heterogeneity and commonality in the immune microenvironment of colorectal cancer and inflammatory bowel disease.
Lv H; Mu Y; Zhang C; Zhao M; Jiang P; Xiao S; Sun H; Wu N; Sun D; Jin Y
Front Immunol; 2024; 15():1356075. PubMed ID: 38529274
[TBL] [Abstract][Full Text] [Related]
3. Role of ferroptosis in the pathogenesis and as a therapeutic target of inflammatory bowel disease (Review).
Ocansey DKW; Yuan J; Wei Z; Mao F; Zhang Z
Int J Mol Med; 2023 Jun; 51(6):. PubMed ID: 37203397
[TBL] [Abstract][Full Text] [Related]
4. The Role of Cyclophilins in Inflammatory Bowel Disease and Colorectal Cancer.
Liang L; Lin R; Xie Y; Lin H; Shao F; Rui W; Chen H
Int J Biol Sci; 2021; 17(10):2548-2560. PubMed ID: 34326693
[TBL] [Abstract][Full Text] [Related]
5. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
6. The Induction Mechanism of Ferroptosis, Necroptosis, and Pyroptosis in Inflammatory Bowel Disease, Colorectal Cancer, and Intestinal Injury.
Zhou P; Zhang S; Wang M; Zhou J
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238692
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species and colorectal cancer.
Lin S; Li Y; Zamyatnin AA; Werner J; Bazhin AV
J Cell Physiol; 2018 Jul; 233(7):5119-5132. PubMed ID: 29215746
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis in colorectal cancer: Potential mechanisms and effective therapeutic targets.
Wang Y; Zhang Z; Sun W; Zhang J; Xu Q; Zhou X; Mao L
Biomed Pharmacother; 2022 Sep; 153():113524. PubMed ID: 36076606
[TBL] [Abstract][Full Text] [Related]
9. Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation.
Salla M; Guo J; Joshi H; Gordon M; Dooky H; Lai J; Capicio S; Armstrong H; Valcheva R; Dyck JRB; Thiesen A; Wine E; Dieleman LA; Baksh S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983040
[TBL] [Abstract][Full Text] [Related]
10. Human umbilical cord mesenchymal stem cells derived exosome shuttling mir-129-5p attenuates inflammatory bowel disease by inhibiting ferroptosis.
Wei Z; Hang S; Wiredu Ocansey DK; Zhang Z; Wang B; Zhang X; Mao F
J Nanobiotechnology; 2023 Jun; 21(1):188. PubMed ID: 37303049
[TBL] [Abstract][Full Text] [Related]
11. Resibufogenin inhibited colorectal cancer cell growth and tumorigenesis through triggering ferroptosis and ROS production mediated by GPX4 inactivation.
Shen LD; Qi WH; Bai JJ; Zuo CY; Bai DL; Gao WD; Zong XL; Hao TT; Ma Y; Cao GC
Anat Rec (Hoboken); 2021 Feb; 304(2):313-322. PubMed ID: 31961485
[TBL] [Abstract][Full Text] [Related]
12. 3,5-diCQA suppresses colorectal cancer cell growth through ROS/AMPK/mTOR mediated mitochondrial dysfunction and ferroptosis.
Wang W; Xu X; Zhao L; Ye K; Wang S; Lin C
Cell Cycle; 2023 Sep; 22(18):1951-1968. PubMed ID: 37902223
[TBL] [Abstract][Full Text] [Related]
13. Role of Inflammation in the Development of Colorectal Cancer.
Muthusami S; Ramachandran IK; Babu KN; Krishnamoorthy S; Guruswamy A; Queimado L; Chaudhuri G; Ramachandran I
Endocr Metab Immune Disord Drug Targets; 2021; 21(1):77-90. PubMed ID: 32901590
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention with phytonutrients and microalgae products in chronic inflammation and colon cancer.
Talero E; Ávila-Roman J; Motilva V
Curr Pharm Des; 2012; 18(26):3939-65. PubMed ID: 22632755
[TBL] [Abstract][Full Text] [Related]
15. Ferroptosis-Mediated Cell Death Induced by NCX4040, The Non-Steroidal Nitric Oxide Donor, in Human Colorectal Cancer Cells: Implications in Therapy.
Sinha BK; Bortner CD; Jarmusch AK; Tokar EJ; Murphy C; Wu X; Winter H; Cannon RE
Cells; 2023 Jun; 12(12):. PubMed ID: 37371096
[TBL] [Abstract][Full Text] [Related]
16. The actin-cytoskeleton pathway and its potential role in inflammatory bowel disease-associated human colorectal cancer.
Kanaan Z; Qadan M; Eichenberger MR; Galandiuk S
Genet Test Mol Biomarkers; 2010 Jun; 14(3):347-53. PubMed ID: 20406101
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory bowel disease and carcinogenesis.
Nagao-Kitamoto H; Kitamoto S; Kamada N
Cancer Metastasis Rev; 2022 Jun; 41(2):301-316. PubMed ID: 35416564
[TBL] [Abstract][Full Text] [Related]
18. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?
Breynaert C; Vermeire S; Rutgeerts P; Van Assche G
Acta Gastroenterol Belg; 2008; 71(4):367-72. PubMed ID: 19317276
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and colorectal cancer.
Kraus S; Arber N
Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer-inflammatory bowel disease nexus and felony of Escherichia coli.
Khan AA; Khan Z; Malik A; Kalam MA; Cash P; Ashraf MT; Alshamsan A
Life Sci; 2017 Jul; 180():60-67. PubMed ID: 28506682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
